MoneyWorks4Me

Balaxi Pharma. - Quaterly Results

23 May 2022 Evaluate
The sales is pegged at Rs. 179.53 millions for the December 2021 quarter. The mentioned figure indicates decline with the sales recorded at Rs. 209.12 millions during the year-ago period.The Net Profit of the company registered a slight decline of -17.64% to Rs. 24.74  millions from Rs. 30.04 millions.Operating Profit reported a sharp decline to 33.78 millions from 40.83 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 179.53 209.12 -14.15 806.45 642.74 25.47 868.71 456.33 90.37
Other Income 4.53 -2.20 -305.91 16.77 17.67 -5.09 18.10 5.95 204.20
PBIDT 33.78 40.83 -17.27 148.35 161.00 -7.86 206.98 92.73 123.21
Interest 0.23 0.00 0.00 0.40 0.00 0.00 0.13 0.00 0.00
PBDT 33.55 40.83 -17.83 147.95 161.00 -8.11 206.85 92.73 123.07
Depreciation 0.79 0.26 203.85 1.72 0.63 173.02 0.88 0.08 1000.00
PBT 32.76 40.57 -19.25 146.23 160.37 -8.82 205.97 92.65 122.31
TAX 8.02 10.53 -23.84 36.80 40.63 -9.43 54.64 27.70 97.26
Deferred Tax 0.03 -0.01 -400.00 0.24 0.03 700.00 0.04 0.04 0.00
PAT 24.74 30.04 -17.64 109.43 119.74 -8.61 151.33 64.95 132.99
Equity 100.00 100.00 0.00 100.00 100.00 0.00 100.00 100.00 0.00
PBIDTM(%) 18.82 19.52 -3.63 18.40 25.05 -26.56 23.83 20.32 17.25
Peers